Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000670074 | SCV000794889 | likely pathogenic | Deficiency of hydroxymethylglutaryl-CoA lyase | 2017-10-18 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000670074 | SCV004199898 | likely pathogenic | Deficiency of hydroxymethylglutaryl-CoA lyase | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000670074 | SCV004456195 | pathogenic | Deficiency of hydroxymethylglutaryl-CoA lyase | 2024-01-25 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln96Argfs*11) in the HMGCL gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in HMGCL are known to be pathogenic (PMID: 9817922, 17692550, 23465862). This variant is present in population databases (no rsID available, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with HMGCL-related conditions. ClinVar contains an entry for this variant (Variation ID: 554439). For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV000670074 | SCV005647163 | likely pathogenic | Deficiency of hydroxymethylglutaryl-CoA lyase | 2024-01-22 | criteria provided, single submitter | clinical testing |